The Haystack Project
  • Home
  • About Us Participants Partners Board and Advisors
  • Priorities
  • PROTECT Rare
  • Rare Disease Approvals HEART Act
  • Speaker Series Payer Engagement Health Equity Rare Cancer
  • Inflation Reduction Act Medicare Section 340b Medicaid FDA ICER
  • Patient Stories
  • Join
  • Take Action
The Haystack Project
  • Home/
  • About/
    • About Us
    • Participants
    • Partners
    • Board and Advisors
  • Priorities/
  • PROTECT Rare/
  • FDA/
    • Rare Disease Approvals
    • HEART Act
  • Programs/
    • Speaker Series
    • Payer Engagement
    • Health Equity
    • Rare Cancer
  • Policy/Comments/
    • Inflation Reduction Act
    • Medicare
    • Section 340b
    • Medicaid
    • FDA
    • ICER
  • Patient Stories/
  • Join/
  • Take Action/
Blue-Banner.png
The Haystack Project

Resources

The Haystack Project
  • Home/
  • About/
    • About Us
    • Participants
    • Partners
    • Board and Advisors
  • Priorities/
  • PROTECT Rare/
  • FDA/
    • Rare Disease Approvals
    • HEART Act
  • Programs/
    • Speaker Series
    • Payer Engagement
    • Health Equity
    • Rare Cancer
  • Policy/Comments/
    • Inflation Reduction Act
    • Medicare
    • Section 340b
    • Medicaid
    • FDA
    • ICER
  • Patient Stories/
  • Join/
  • Take Action/
November 10, 2023

Politico AgencyIQ Article: NASEM meeting kicks off study on FDA and EMA processes for rare disease drugs→

November 10, 2023/ Tiara Logan

Link to the article with press coverage of the meeting. See page 3 for what the reporter had to say about Haystack’s participation.

November 10, 2023/ Tiara Logan/ /Source
news, FDA

Tiara Logan

March 30, 2023

Press Release: Victoria Blatter Joins Haystack Project’s Board of Directors→

March 30, 2023/ Michelle Osburn

Read more.

March 30, 2023/ Michelle Osburn/ /Source
news, Haystack

Michelle Osburn

December 06, 2022

Haystack Responds to CMS’ National Provider Directory RFI→

December 06, 2022/ Michelle Osburn

Read more.

December 06, 2022/ Michelle Osburn/ /Source
Comment Letters
advocacy, medicare, news, other issues

Michelle Osburn

November 30, 2022

Haystack response to 2022 National Strategy to Support Family Caregivers→

November 30, 2022/ Michelle Osburn

Read more.

November 30, 2022/ Michelle Osburn/ /Source
Comment Letters
other issues, news

Michelle Osburn

November 18, 2022

Haystack's Comments to Congressional Leadership on HEART Act Provisions→

November 18, 2022/ Michelle Osburn

Read more.

November 18, 2022/ Michelle Osburn/ /Source
Comment Letters
news, HEART Act

Michelle Osburn

September 07, 2022

FDA needs to be more flexible assessing rare →

September 07, 2022/ Michelle Osburn

Read more.

September 07, 2022/ Michelle Osburn/ /Source
Patient Stories
news

Michelle Osburn

June 17, 2022

Haystack Project's reply to CMS' Hospital Inpatient Prospective Payment Systems→

June 17, 2022/ Michelle Osburn

Read more.

June 17, 2022/ Michelle Osburn/ /Source
Letters
medicare, news

Michelle Osburn

June 14, 2022

Press Release: Haystack Project Applauds the Inclusion of the HEART Act in the User Fee Package→

June 14, 2022/ Michelle Osburn

Read more.

June 14, 2022/ Michelle Osburn/ /Source
Reports
HEART Act, news

Michelle Osburn

April 28, 2022

New bill calls for more data and new development approaches on orphan drug development→

April 28, 2022/ Michelle Osburn

Read more.

April 28, 2022/ Michelle Osburn/ /Source
news

Michelle Osburn

March 07, 2022

STAT on Access to Rare Indications Act

March 07, 2022/ Michelle Osburn

Read more here.

March 07, 2022/ Michelle Osburn/ /Source
news, rare

Michelle Osburn

February 10, 2022

Haystack Project's sign-on letter commenting to CMS' proposed NCA for monoclonal antibodies→

February 10, 2022/ Michelle Osburn

Read more.

February 10, 2022/ Michelle Osburn/ /Source
Letters, Comment Letters, Position Statements
news, medicare, medicaid, other issues

Michelle Osburn

January 10, 2022

Press Release: New Report for Uveal Melanoma Patients→

January 10, 2022/ Michelle Osburn

Read more.

January 10, 2022/ Michelle Osburn/ /Source
Reports
press release, news

Michelle Osburn

About Us

The Issues

Resources

News & Updates

© 2020 Haystack Project. All Rights Reserved. 

 

Contact Us

Please consider making a tax-deductible donation to support the Haystack Project today.

The Haystack Project is a 501(c)3 nonprofit that brings together patients organizations representing patients suffering from or caring for patients with extremely rare diseases. Our mission is to educate policymakers and other stakeholders about the need for policies that recognize the unique circumstances of extremely rare conditions and treatments and expand incentives critical to ensuring they can reach patients.